SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-205370
Filing Date
2024-08-22
Accepted
2024-08-22 16:15:51
Documents
13
Period of Report
2024-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d884557d8k.htm   iXBRL 8-K 22763
  Complete submission text file 0001193125-24-205370.txt   144655

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aadi-20240816.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20240816_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20240816_pre.xml EX-101.PRE 11255
15 EXTRACTED XBRL INSTANCE DOCUMENT d884557d8k_htm.xml XML 3650
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 241232180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)